EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FOXA2 Suppression by TRIM36 Exerts Anti‐Tumor Role in Colorectal Cancer Via Inducing NRF2/GPX4‐Regulated Ferroptosis

Xin Liu, Chunli Yan, Chunxiao Chang, Fansong Meng, Wenjie Shen, Song Wang, Yi Zhang iD

Advanced Science · 2023-12 · 10 (35)

DOI: 10.1002/advs.202304521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 24.10.2023. Verfasst von Xin Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Scien…. Hauptthemen laut MEDLINE: Ferroptosis, Colorectal Neoplasms. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong First Medical University & Shandong Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The forkhead box transcription factor A2 (FOXA2) is a transcription factor and plays a key role in embryonic development, metabolism homeostasis and tumor cell proliferation; however, its regulatory potential in CRC is not fully understood. Here, it is found that FOXA2 expression is markedly up‐regulated in tumor samples of CRC patients as compared with the normal tissues, which is closely associated with the worse survival in patients with CRC. Notably, a positive correlation between FOXA2 and nuclear factor erythroid 2‐related factor 2 (Nrf2)/glutathione peroxidase 4 (GPX4) gene expression is observed in CRC patients. Mechanistically, FOXA2 depletion weakens the activation of Nrf2 pathway and decreases GPX4 level in CRC cells, thereby leading to ferroptosis, which is further supported by bioinformatic analysis. More intriguingly, the E3 ubiquitin ligase tripartite motif containing 36 (TRIM36) is identified as a key suppressor of FOXA2, and it is observed that TRIM36 can directly interact with FOXA2 and induce its K48‐linked polyubiquitination, resulting in FOXA2 protein degradation in vitro. Taken together, all the studies demonstrate that FOXA2 mediated by TRIM36 promotes CRC progression by inhibiting the Nrf2/GPX4 ferroptosis signaling pathway, thus providing a new therapeutic target for CRC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisColorectal NeoplasmsFemalePregnancyHumansPhospholipid Hydroperoxide Glutathione PeroxidaseNF-E2-Related Factor 2Cell ProliferationTripartite Motif ProteinsUbiquitin-Protein LigasesHepatocyte Nuclear Factor 3-beta

Stichwörter der Autor:innen

FOXA2Nrf2/GPX4TRIM36colorectal cancer (CRC)ferroptosis

Substanzen

Phospholipid Hydroperoxide Glutathione PeroxidaseNF-E2-Related Factor 2TRIM36 protein, humanTripartite Motif ProteinsUbiquitin-Protein LigasesFOXA2 protein, humanHepatocyte Nuclear Factor 3-beta

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Department of Breast Internal Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Ward 2 of Gastroenterology, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Department of Medical Management, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Clinical Trial Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.

ORCID-Profile: Yi Zhang

Förderung

  • Shandong First Medical University & Shandong Academy of Medical Sciences

Zitieren

APA

Liu, X., Yan, C., Chang, C., Meng, F., Shen, W., Wang, S., & Zhang, Y. (2023). FOXA2 Suppression by TRIM36 Exerts Anti‐Tumor Role in Colorectal Cancer Via Inducing NRF2/GPX4‐Regulated Ferroptosis. Advanced Science, 10(35). https://doi.org/10.1002/advs.202304521

Vancouver

Liu X, Yan C, Chang C, Meng F, Shen W, Wang S, et al. FOXA2 Suppression by TRIM36 Exerts Anti‐Tumor Role in Colorectal Cancer Via Inducing NRF2/GPX4‐Regulated Ferroptosis. Advanced Science. 2023;10(35). doi:10.1002/advs.202304521

BibTeX
@article{Liu2023,
  author = {Liu, Xin and Yan, Chunli and Chang, Chunxiao and Meng, Fansong and Shen, Wenjie and Wang, Song and Zhang, Yi},
  title = {FOXA2 Suppression by TRIM36 Exerts Anti‐Tumor Role in Colorectal Cancer Via Inducing NRF2/GPX4‐Regulated Ferroptosis},
  journal = {Advanced Science},
  year = {2023},
  volume = {10},
  number = {35},
  doi = {10.1002/advs.202304521}
}
Kostenlos starten →